On Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia. The approval covers patients requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents. In March, by a 12-to-2 margin, the FDA adcomm panel voted in favor of the benefits of imetelstat, st
Keith Gill, aka Roaring Kitty, aka DeepF***ingValue, is again making headlines. But a passing comment he made years ago seems to have signaled today’s developments. On Dec. 20, 2020, under a post where Gill revealed his $3.4 million position in GameStop (GME), a Reddit user asked him, "Seriously what is your exit strategy here" Gill’s response was a simple yet cryptic, "What’s an exit strategy?" Don't Miss: A startup that turns videos into games gets backing from Mark Cuban and opens a round for